CBC & Mubadala in Neurology and Allergy Play
27 Aug 2024
US$ 19.00
CBC Group and Mubadala Investment Co have agreed to buy the neurology and allergy business in China from UCB SA ......
Related Publications
UK-based Octopus Ventures has joined hands with Movac Ltd to co-lead the A$80 m (US$56 m) series B funding round of...
Sorin Investments has led the US$7 m series A funding round of Nivaan Care, which specialises in chronic pain...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.